uniQure N.V.'s AMT-130 demonstrated an 80% reduction in disease progression for high-dose patients, supported by biomarker data. Huntington's disease affects 41,000 people in the U.S., and the market ...
The alternative minimum tax (AMT) is a separate way to calculate taxes that makes sure high-income earners pay at least a minimum amount, even if they claim many deductions or credits. In 2025, the ...
uniQure recently divested from its Lexington facility to Genezen and freed $25 million while significantly reducing its operating costs. At the same time, AMT-130 has received the FDA’s Breakthrough ...
uniQure announces FDA's Breakthrough Therapy designation for AMT-130, with promising Phase I/II trial safety data and upcoming regulatory updates. uniQure N.V. has announced that its gene therapy ...
uniQure N.V. has announced progress regarding its investigational gene therapy AMT-130 for Huntington's disease, aligning with the FDA on key components necessary for a Biologics License Application ...
SmartAsset on MSN
Who Actually Has to Pay the Alternative Minimum Tax (AMT)?
The alternative minimum tax (AMT) was designed to ensure that high-income individuals and trusts pay a minimum level of tax, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback